Cargando…
Polysaccharide K suppresses angiogenesis in colon cancer cells
The protein-bound polysaccharide K (PSK) is used as a non-specific immunotherapeutic agent for the treatment of colon cancer. Little research, however, has been conducted on its association with angiogenesis, which is a prognostic factor markedly correlated with hematogenous metastases. We therefore...
Autores principales: | SATOH, YOSHIKI, GOI, TAKANORI, NAKAZAWA, TOSHIYUKI, KIMURA, YOUHEI, HIRONO, YASUO, KATAYAMA, KANJI, YAMAGUCHI, AKIO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503532/ https://www.ncbi.nlm.nih.gov/pubmed/23181101 http://dx.doi.org/10.3892/etm.2012.632 |
Ejemplares similares
-
CD44variant exon 9 plays an important role in colon cancer initiating cells
por: Kimura, Youhei, et al.
Publicado: (2013) -
MUC2 protein expression status is useful in assessing the effects of hyperthermic intraperitoneal chemotherapy for peritoneal dissemination of colon cancer
por: FUJISHIMA, YUKA, et al.
Publicado: (2012) -
Prokineticin 2 (PROK2) is an important factor for angiogenesis in colorectal cancer
por: Kurebayashi, Hidetaka, et al.
Publicado: (2015) -
Response to Modified TEGAFIRI in a Patient with Synchronous Multiple Liver Metastases of Colon Cancer
por: Takanori, Goi, et al.
Publicado: (2011) -
The anti-tumor effect is enhanced by simultaneously targeting VEGF and PROK1 in colorectal cancer
por: Goi, Takanori, et al.
Publicado: (2015)